IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECs

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 9, 2012, Pages 746-751

  Yu, Xiaofeng ^a   Xing, Chunyan ^b   Pan, Yinghua ^a   Ma, Housheng ^a   Zhang, Jie ^c   Li, Wenjun ^a  

^a YANTAI YUHUANGDING HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

high mobility group box 1; human aortic endothelial cells; inflammation; insulin like growth factor 1

Indexed keywords

DRUG DERIVATIVE; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PICROPODOPHYLLIN; PODOPHYLLOTOXIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

AORTA; ARTICLE; CELL LINE; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION; GENETICS; HUMAN; INFLAMMATION; METABOLISM; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME; WESTERN BLOTTING;

AORTA; BLOTTING, WESTERN; CELL LINE; ENDOTHELIAL CELLS; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; MICROSCOPY, CONFOCAL; OXIDATION-REDUCTION; PHOSPHORYLATION; PODOPHYLLOTOXIN; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME FACTORS;

EID: 84865601970     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms059     Document Type: Article

References (39)

1. Croce K and Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 2007, 14: 55-61. (Pubitemid 44885613)
2. Farmer JA and Torre-Amione G. Atherosclerosis and inflammation. Curr Atheroscler Rep 2002, 4: 92-98.
3. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA and Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93: 241-252. (Pubitemid 28180857)
4. Steinberg D and Lewis A. Conner memorial lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997, 95: 1062-1071. (Pubitemid 27091554)
5. Silverstein RL. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 2009, 76(Suppl. 2): S27-S30.
6. Andersson U and Rauvala H. Introduction: HMGB1 in inflammation and innate immunity. J Intern Med 2011, 270: 296-300.
7. Huttunen HJ and Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med 2004, 255: 351-366. (Pubitemid 38315276)
8. Schierbeck H, Lundback P, Palmblad K, Klevenvall L, Erlandsson-Harris H, Andersson U and Ottosson L. Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mol Med 2011, 17: 1039-1044.
9. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME and Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002, 3: 995-1001. (Pubitemid 35256475)
10. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP and Arnold B, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005, 174: 7506-7515. (Pubitemid 40806253)
11. Hamada T, Torikai M, Kuwazuru A, Tanaka M, Horai N, Fukuda T and Yamada S, et al. Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthritis Rheum 2008, 58: 2675-2685.
12. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A and Rubartelli A, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003, 22: 5551-5560. (Pubitemid 37279964)
13. Scaffidi P, Misteli T and Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418: 191-195. (Pubitemid 34773774)
14. Bell CW, Jiang W, Reich CF, III and Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006, 291: C1318-C1325. (Pubitemid 44878603)
15. Lotze MT and Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5: 331-342. (Pubitemid 40516158)
16. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH and Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101: 2652-2660. (Pubitemid 36857626)
17. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F and Maseri A, et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 2006, 20: 2565-2566.
18. Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR and Sheng ZY. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury. Shock 2002, 17: 329-333.
19. Abraham E, Arcaroli J, Carmody A, Wang H and Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165: 2950-2954.
20. Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G and Ilyinskaya O, et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004, 24: 2320-2325. (Pubitemid 39658036)
21. Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F and Arrigoni G, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001, 152: 1197-1206. (Pubitemid 34280177)
22. Payne JF, Tangpricha V, Cleveland J, Lynn MJ, Ray R and Srivastava SK. Serum insulin-like growth factor-i in diabetic retinopathy. Mol Vis 2011, 17: 2318-2324.
23. Foncea R, Andersson M, Ketterman A, Blakesley V, Sapag-Hagar M, Sugden PH and LeRoith D, et al. Insulin-like growth factor-i rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem 1997, 272: 19115-19124. (Pubitemid 27337697)
24. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y and Kajstura J, et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997, 100: 1991-1999. (Pubitemid 27459352)
25. Mizuno Y, Jacob RF and Mason RP. Inflammation and the development of atherosclerosis. J Atheroscler Thromb 2011, 18: 351-358.
26. Zhang S, Zhong J, Yang P, Gong F and Wang CY. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol 2009, 3: 24-38.
27. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999, 19: 5237-5246. (Pubitemid 29339883)
28. Stros M and Reich J. Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box b-domain of hmg1 protein to supercoiled DNA. Eur J Biochem 1998, 251: 427-434. (Pubitemid 28080943)
29. Bianchi ME, Beltrame M and Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1. Science 1989, 243: 1056-1059. (Pubitemid 19072581)
30. Ueda T, Chou H, Kawase T, Shirakawa H and Yoshida M. Acidic C-tail of HMGB1 is required for its target binding to nucleosome linker DNA and transcription stimulation. Biochemistry 2004, 43: 9901-9908. (Pubitemid 38993839)
31. Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X and Harris HE, et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 2003, 9: 37-45. (Pubitemid 36667690)
32. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME and Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 2005, 26: 381-387. (Pubitemid 40835844)
33. Ulloa L and Messmer D. High-mobility group box 1 (HMGB1) protein:-friend and foe. Cytokine Growth Factor Rev 2006, 17: 189-201. (Pubitemid 43949075)
34. Li D, Chen H, Romeo F, Sawamura T, Saldeen T and Mehta JL. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther 2002, 302: 601-605. (Pubitemid 34787225)
35. Liu JP, Baker J, Perkins AS, Robertson EJ and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor i (igf-1) and type 1 IGF receptor (igf1r). Cell 1993, 75: 59-72. (Pubitemid 23306021)
36. Baker J, Liu JP, Robertson EJ and Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:73-82. (Pubitemid 23306022)
37. LeRoith D, Werner H, Beitner-Johnson D and Roberts CT, Jr. Molecular and cellular aspects of the insulin-like growth factor 1 receptor. Endocr Rev 1995, 16: 143-163.
38. Huynh K, McMullen JR, Julius TL, Tan JW, Love JE, Cemerlang N and Kiriazis H, et al. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes 2010, 59: 1512-1520.
39. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A and Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004, 279: 7370-7377. (Pubitemid 38294612)